L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
75,700
+300 (0.40%)
Mar 20, 2026, 3:30 PM KST
Market Cap1.88T +288.4%
Revenue (ttm)79.99B +19.4%
Net Income78.00B
EPS3,050.54
Shares Out24.85M
PE Ratio24.60
Forward PE132.57
Dividend50.00 (0.07%)
Ex-Dividend DateDec 29, 2025
Volume170,859
Average Volume379,609
Open76,200
Previous Close75,400
Day's Range74,900 - 77,400
52-Week Range18,490 - 125,000
Beta1.47
RSI42.38
Earnings DateMar 24, 2026

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 141
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2024, L&C BIO Co.,LTD's revenue was 72.09 billion, an increase of 9.35% compared to the previous year's 65.93 billion. Earnings were 141.06 billion, an increase of 191.69%.

Financial Statements